Syphilis: Treponemal Antibodies With Reflex to RPR and RPR Titer, Reverse Screening and Diagnosis Algorithm
Also known as: Syphilis, Trep-Sure™, Treponemal
Use
This test is intended to support screening and diagnosis of syphilis infections. This test aligns with the CDC-supported reverse serologic testing algorithm for syphilis using a combination of both treponemal and nontreponemal antibody tests. The reverse syphilis testing algorithm begins with a treponemal antibody assay. Positive samples reflex to RPR (nontreponemal). If the RPR is positive, RPR titer will be determined. If the RPR is negative, a second treponemal antibody assay will be performed to confirm the presence of treponemal antibodies. Interpretation of results obtained must take into account patient symptoms and clinical history.
Special Instructions
N/A
Limitations
Treponemal antibodies tend to persist for life despite treatment, making this assay unsuitable for monitoring response to treatment or assessing treatment outcomes. False-positive results can occur in individuals with non-syphilis treponemal infections like bejel, pinta, and yaws.
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 47236-5
- 47236-5
- 20507-0
- 31147-2
- 24312-1
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Room temperature
Causes for Rejection
Grossly hemolyzed; grossly lipemic; gross bacterial contamination; plasma specimen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
